Everything
Henrico Doctors' Hospital - Home Page
Henrico Doctors' Hospital provides Emergency, Medical, Surgical & Weight Loss services. Our advance offering includes Cardiac Care, Women's Health, Oncology, Orthopedics and daVinci Robotic Surgery.
Gene Medicine - Gene Medicine Xagena
GeneMedicine News Xagena Medicine Xagena.net Beta-thalassemia: successful results of gene therapy treatment Leber congenital amaurosis type 2: gene therapy improves vision Liver an excellent target for cancer gene therapy using viral vectors Peripheral arterial disease: gene therapy shows promise
Difficulties Concerning Differences Between Mesothelioma And Lung Cancer. | PRLog
Difficulties Concerning Differences Between Mesothelioma And Lung Cancer. The Health & Safety Executive figures for the current annual, total number of asbestos-related cancer deaths in the UK is a conservative 4,000. Even though there were 2249 known deaths from mesothelioma... - PR11732980
Common Gene Disorder Doubles Risk of Lung Cancer
Mayo Clinic researchers have found that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers.
Clinicopathological Characteristics and Prognosis of Non-Small Cell Lung Cancer Patients Associated
<p><b>Introduction: </b>Clinicopathological characteristics and prognosis of non-small cell lung cancer (NSCLC) patients with a family history of lung cancer (FHLC) have not been well established.</p><p><b>Methods</b>: Clinical records of patients with NSCLC treated at our institute from 1982 to
ALCMI Forms Clinical Research Collaboration With Response Genetics - Pharmaceutical Business Review
Tissue bank to be housed at the Los Angeles laboratory facility of Response Genetics
Pharmacyclics, Inc. - Pharmacyclics' Xcytrin New Drug Application for Treatment of Lung Cancer
Pharmacyclics, Inc. Logo Print Print page | Email Email page | PDF Download PDF | Add to Briefcase Add to briefcase « Previous Release | Next Release » Pharmacyclics' Xcytrin New Drug Application for Treatment of Lung Cancer Brain Metastases to Be Filed Over Protest
Myriad Genetics, Inc. - Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Lung Cancer
Myriad Genetics, Inc. Logo Print Print page Email Email page PDF Download PDF Add to Briefcase « Previous Release | Next Release » Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa in Lung Cancer 80% of Lung Cancer Cases Spread to the Brain Salt Lake City, UT, Aug 16,
Abbott Completes Submission of New Molecular Test Intended for Non-small-cell Lung Cancer Therapy
Abbott Completes Submission of New Molecular Test Intended for Non-small-cell Lung Cancer Therapy Selection
Scottish lung cancer patients to be denied drug prescribed in England - Scotsman.com News
Scottish lung cancer patients to be denied drug prescribed in England - SCOTTISH patients with a specific type of lung cancer are to be denied access to a drug approved for use in England, campaigners have warned.<br />
Refine by Content Type:
- News and Blogs (554)
- News (544)
- Forums (192)
- Press Releases (106)
- Blogs (10)
- Resource (5)
- Video (3)
- Events (1)
- Images (1)
Refine by Source:
- www.thelancet.com (338)
- download.thelancet.com (201)
- forums.webmd.com (192)
- www.medpagetoday.com (54)
- www.prlog.org (52)
- www.aerzteblatt.de (36)
- www.biospace.com (31)
- www.imt.ie (27)
- www.webmd.com (26)
- www.genengnews.com (25)
- ir.pharmacyclics.com (24)
- www.em-consulte.com (22)

